BPC-157 vs Kpv for pain & inflammation
Short answer: For pain & inflammation, more users report improvement with Kpv — 100% of 10 reports, versus 86% of 485 for BPC-157.
BPC-157 has 0 meta-analyses and 0 randomized trials on PubMed; Kpv has 1 and 0.
Based on 1,613 reports about BPC-157 and 74 about Kpv. Not medical advice.
| BPC-157 Peptide | Kpv Peptide | |
|---|---|---|
| Users say it helped | 54%helped919 reports · high confidence | 85%helped24 reports · medium confidence |
| Verdict | Mixed | Mostly positive |
| Research | DResearch: None | BResearch: Moderate |
| Meta-analyses / RCTs | 0 / 0 | 1 / 0 |
| Mainly used for | ||
| Recovery % reporting improvement | 96% (494) | 100% (3) |
| Pain & inflammation % reporting improvement | 86% (485) | 100% (10) |
| Mood % reporting improvement | 65% (128) | — |
| Digestion % reporting improvement | 84% (111) | 100% (5) |
| Sleep % reporting improvement | 80% (76) | — |
| Common side effects | fatigue, anhedonia, anxiety, headache | malabsorption, green stool, weight loss, allergic reaction |
| Typical dose reported | Not listed | Not listed |
BPC-157Full BPC-157 profile →
What a user said
“after 2+ years of nothing working, this is the 1st thing to reverse significant muscle damage ... 40% increase in my range of motion, and nearly the same in muscle strength.”
KpvFull Kpv profile →
Latest review conclusion
PCI using drug-eluting stents and CABG are equally safe methods of revascularization for patients at low surgical risk with significant unprotected left main coronary artery stenosis. However, CABG is associated with significantly lower rates of repeat revascularization.
Circ Cardiovasc Interv, 2016 ↗What a user said
“KPV has been my MVP (har-har). ... KPV helps tremendously. I’ve had a massive reduction in pain.”
Related comparisons
Percentages come from first-hand user reports and are not clinical outcomes. Talk to a doctor before starting, stopping or combining anything. How we rate